v3.26.1
Revenues (Tables)
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The Company’s revenues disaggregated by geography, based on the destination to which the Company ships its products, for the three months ended March 31, 2026 and 2025 was as follows (in thousands):
 
Three Months Ended March 31,
 
2026
2025
United States
$
296,387 
$
256,860 
International
78,371 
67,280 
Total
$
374,758 
$
324,140 
The Company’s revenues disaggregated by product category for the three months ended March 31, 2026 and 2025 was as follows (in thousands):
 
Three Months Ended March 31,
 
2026
2025
Thrombectomy
$
253,917 
$
226,544 
Embolization and Access
120,841 
97,596 
Total
$
374,758 
$
324,140 
Summary of Contract Assets
The following information summarizes the Company’s contract assets (in thousands):
March 31, 2026
December 31, 2025
Contract assets
$
18,000 
$
18,000